Table 1 Clinical-pathological characteristics of goiter and patients of Group 1 – no sternotomy (n = 40 patients) and Group 2 – associated sternotomy (n = 4 patients)
Group 1 (n = 40) | Group 2 (n = 4) | p | ||
|---|---|---|---|---|
Age | years (medium ± SD) | 58,63 ± 9,67 | 67,5 ± 4,36 | 0,075 |
(range) | (39–79) | (64–73) | ||
fT4 | ng/dL (medium ± SD) | 9,45 ± 2,09 | 6,52 ± 3,78 | 0,068 |
(range) | (2,0 - 14,3) | (0,9 - 9,0) | ||
TSH | mUI/L (medium ± SD) | 1,45 ± 2,27 | 1,32 ± 0,73 | 0,515 |
(range) | (0,073 - 13,62) | (0,278 - 1,97) | ||
Presence of goiter | years (medium ± SD) | 8,40 ± 4,27 | 14,75 ± 1,89 | 0,008 |
(range) | (3–20) | (12–16) | ||
Thyroid’s weight | gr (medium ± SD) | 127,00 ± 73,18 | 227,00 ± 32,19 | 0,02 |
(range) | (45–385) | (193–257) | ||
Post-operative serum calcium | mg/dL (medium ± SD) | 8,39 ± 0,67 | 9,17 ± 0,84 | 0,169 |
(range) | (7,4 - 10,7) | (8,2 - 9,7) | ||
PTH | pg/mL (medium ± SD) | 18,74 ± 27,47 | 15,50 ± 12,38 | 0,875 |
(range) | (1,3 - 140,0) | (1,5 - 25,0) | ||
Presence of symptoms | yes (%) | 23 (57,5%) | 3 (75,0%) | 0,455 |
not (%) | 17 (42,5%) | 1 (25,0%) | ||
Extension to the aortic arch | above (%) | 40 (100%) | 1 (25,0%) | 0,0001 |
below (%) | 0 (0%) | 3 (75,0%) | ||
Lateral extension of goiter | right (%) | 11 (27,5%) | 1 (25,0%) | 0,583 |
left (%) | 25 (62,5%) | 2 (50,0%) | ||
bilateral (%) | 4 (10,0%) | 1 (25,0%) | ||
Histological malignancy | yes (%) | 6 (15,0%) | 1 (25,0%) | 0,513 |
not (%) | 34 (85,0%) | 3 (75,0%) | ||
Histological thyroiditis | yes (%) | 6 (15,0%) | 3 (75,0%) | 0,023 |
not (%) | 34 (85,0%) | 1 (25,0%) |